The story of Viagra presents a interesting case for stakeholders in the pharmaceutical sector. While initially a phenomenal success, creating vast sums, the exclusivity end and the subsequent entry of off-brand https://adult130407.dgbloggers.com/42193657/sildenafil-and-big-pharma-a-hazardous-play